ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases. 

Biotechnology

ReCode Therapeutics

ReCode Therapeutics' headquarters in Menlo Park, CA, United States

Shehnaaz Suliman

Max Barker

Jessica Kelly

Carol Wolf

David J Lockhart

Julia Bushkov

Join Our Talent Community

Ariel Kantor

Erica V. Jefferson

Alan Colowick

Helen S. Kim

Peter Thompson

Ed Hurwitz

Oleg Nodelman

Rana Al-Hallaq

Justin Hanes

Trisha Millican

Carrolee Barlow

Rafael Amado

Elliott Sigal

Daniel J. Siegwart

Eric Olson

The Research and Development team at ReCode Therapeutics focuses on advancing targeted, disease-modifying therapies for life-limiting respiratory diseases. This diverse group of scientists and researchers works on various aspects of drug discovery and development, including gene editing, in vivo and in vitro pharmacology, formulation, process development, and bioanalytical assay development, to bring innovative genetic medicines from concept to clinical application.

Research and Development

The Directors Team at ReCode Therapeutics consists of senior leaders responsible for steering various strategic aspects of the company, including research and development, clinical operations, supply chain management, program management, and financial oversight. This team collaborates to ensure that the company’s genetic medicines for respiratory diseases are effectively developed, managed, and brought to market, aligning with overall business goals and regulatory standards.

Directors Team

The Leadership Team at ReCode Therapeutics spearheads the strategic direction and operational oversight of the company, ensuring alignment with its mission to develop innovative genetic therapies for respiratory diseases. Comprising senior executives with expertise in business development, scientific research, and manufacturing, this team collaborates to drive research initiatives, foster partnerships, and navigate regulatory landscapes, ultimately aiming to bring transformative treatments to patients in need.

Leadership Team

The Business Development & Strategy team at ReCode Therapeutics is responsible for identifying and executing growth opportunities, forging strategic partnerships, overseeing financial planning, managing legal and intellectual property matters, and driving the overall business strategy to advance the company's mission of developing therapies for life-limiting respiratory diseases.

Business Development & Strategy

The Human Resources and Operations team at ReCode Therapeutics is responsible for managing and optimizing the company's human capital and operational efficiency. This includes talent acquisition, employee relations, facilities management, business operations, and ensuring the seamless functioning of laboratory environments, ultimately supporting the company's mission to develop targeted therapies for respiratory diseases.

Human Resources and Operations

The Research and Development team at ReCode Therapeutics focuses on discovering and advancing innovative genetic therapies for respiratory diseases. By integrating preclinical biology, clinical development, and strategic operations, they aim to develop targeted treatments that significantly improve patient outcomes.

ReCode Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Directors Team

Leadership Team

Business Development & Strategy

Human Resources and Operations

Research and Development

Offices

ReCode Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Directors Team

Leadership Team

Business Development & Strategy

Human Resources and Operations

Research and Development

Offices

Related companies